REGENXBIO, Inc. RGNX
NASDAQ · United States · Health Technology
$7.42-0.11 (-1.46%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Momentum and volatility snapshot
| Average | Value | Price vs. average |
|---|---|---|
| 20-period average | $8.19 | -9.40% · below |
| 50-period average | $9.39 | -20.94% · below |
| 200-period average | $9.94 | -25.37% · below |
| Avg. volume (1Y) | 1.24M |
Total return, dividends included.
All indicators are computed from the last year of daily closes. Returns and volatility use the dividend-adjusted series; averages and highs/lows use the traded price. Not investment advice.